Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Graefe's Archive for Clinical and Experimental Ophthalmology
Literatur
1.
Chatziralli I, Theodossiadis G, Kabanarou SA, Parikakis E, Xirou T, Mitropoulos P, Theodossiadis P (2017) Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the Ranidex study. Graefes Arch Clin Exp Ophthalmol. doi:10.​1007/​s00417-017-3719-5 Published online June 15, 2017
2.
Freund KB, Korobelnik JF, Deveny R et al (2015) Treat-and extend regimens with anti-VEGF agents in retinal diseases. Retina 35:1489–1506CrossRefPubMed
3.
Gover S, Murthy RK, Brar VS, Chalam KV (2009) Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (Spectralis). Am J Ophthalmol 148:266–271CrossRef
4.
Kuppermann BD, Haller JA, Bandello F (2014) Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to vcretinal vein occlusion. Retina 34:1743–1749CrossRefPubMed
5.
Campochiaro PA, Brown DM, Awh CC, Lee SY, Gray S, Saroj N, Murahashi WY, Rubio RG (2011) Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase lll study. Ophthalmology 118:2041–2049CrossRefPubMed
6.
Haller JA, Bandello F, RJr B, Blumenkranz MS, Gilles M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM (2011) Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results. Ophthalmology 118(Ozurdex Geneva Study Group):2453–2560CrossRefPubMed
7.
Călugăru D, Călugăru M (2015) Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study. J Ocul Pharmacol Ther 31:78–86CrossRefPubMed
8.
Călugăru D, Călugăru M (2017) Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA. Eye 31:1112–1113
9.
Călugăru D, Călugăru M (2017) Baseline choroidal thickness as a predictor for treatment oucomes in central retinal vein occlusion. Am J Ophthalmol 176:257–258PubMed
10.
Călugăru D, Călugăru M (2017) Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial. Graefes Arch Clin Exp Ophthalmol 255:427–428CrossRefPubMed
Metadaten
Titel
Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the Ranidex study
verfasst von
Dan Călugăru
Mihai Călugăru
Publikationsdatum
25.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 10/2017
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-017-3749-z

Weitere Artikel der Ausgabe 10/2017

Graefe's Archive for Clinical and Experimental Ophthalmology 10/2017 Zur Ausgabe

Neurophthalmology

Steroid intra-trochlear injection for the treatment of acquired Brown syndrome secondary to trochleitis

Review Article

Treatment of retinal artery occlusion using transluminal Nd:YAG laser: a systematic review and meta-analysis

Basic Science

Post-hypoxic constriction of retinal arterioles is impaired during nitric oxide and cyclo-oxygenase inhibition and in diabetic patients without retinopathy

Glaucoma

One-year efficacy of adjunctive use of Ripasudil, a rho-kinase inhibitor, in patients with glaucoma inadequately controlled with maximum medical therapy

Glaucoma

Baerveldt® glaucoma implant surgery with the double scleral flap technique to prevent Hoffman elbow exposure

Basic Science

Retinal VEGF levels correlate with ocular circulation measured by a laser speckle-micro system in an oxygen-induced retinopathy rat model

Neu im Fachgebiet Augenheilkunde

08.04.2024 | Therapieverfahren in der Augenheilkunde | CME

Ophthalmika in der Schwangerschaft

08.03.2024 | Vitrektomie | Originalien

Operative Therapie und Keimnachweis bei endogener Endophthalmitis
Datenauswertung aus 5 Augenkliniken

04.03.2024 | Vitrektomie | Leitthema

Bakterielle endogene Endophthalmitis
Erregerspektrum und medikamentöse Therapie

27.02.2024 | Erkrankungen der Hornhaut | CME

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen